Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

32 filings reported holding ACHL - Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share as of Q3 2021.
Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17.6M shares of 41.1M outstanding shares and own 42.79% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (5.01M shares), BAKER BROS. ADVISORS LP (2.59M shares), Artal Group S.A. (2.26M shares), Redmile Group, LLC (2.09M shares), ORBIMED ADVISORS LLC (1.58M shares), BOXER CAPITAL, LLC (1.54M shares), PERCEPTIVE ADVISORS LLC (755K shares), Point72 Asset Management, L.P. (500K shares), FARALLON CAPITAL MANAGEMENT LLC (450K shares), and AXA S.A. (279K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.